癌症疫苗产业市场的现状与发展趋势  

The current status and trends in the cancer vaccine market

作　　者：高云华[1] 吴曙霞[1] 刁天喜[1] 

机构地区：[1]军事医学科学院卫生勤务与医学情报研究所,北京100850

出　　处：《中国新药杂志》2008年第19期1641-1643,共3页Chinese Journal of New Drugs

基　　金：国家高技术研究发展计划(863计划)(2006AA02Z316)

摘　　要：虽然目前癌症疫苗在疫苗产业市场中所占份额较小,但作为新兴的疫苗产业市场,已凸显出了其发展的强劲势头。目前已批准上市的癌症疫苗主要有膀胱癌疫苗、宫颈癌疫苗、结肠直肠癌疫苗、黑素瘤癌疫苗等,此外,尚有大批癌症疫苗正处于研发的各个阶段。现对癌症疫苗产业市场的现状与发展趋势做一介绍。Currently, the cancer vaccine has a small share in the vaccine market; but as an emerging vaccine market, its powerful momentum on commercial development has been released. Although cancer vaccines are currently limited to a small number of cancers, the vaccines approved for market have provided not only a new choice for cancer patients, but also rather better therapeutic agents for a large number of patients who are in treatment. At present, the major approved cancer vaccines are bladder carcinoma vaccine, cervix cancer vaccine, colorectal cancer vaccine and melanoma cancer vaccine. In addition, a large amount of cancer vaccines arc developed in various stages.

关 键 词：癌症疫苗 产业市场 发展趋势 

分 类 号：R979.5[医药卫生—药品]